Are you a resident of the US and over 21 years of age? Join our COVID-Cough Study

Instantly diagnose and manage respiratory disease using only a smartphone.

We provide point of care diagnostic solutions for telehealth that are easily integrated into existing platforms. We are working on apps to provide instant clinical quality diagnostic tests and management tools directly to consumers and healthcare providers.

ResAppDx is CE Marked in Europe and TGA approved in Australia.

See how ResApp improves telehealth

A world-leading technology platform

Over the last five years the research team, led by Associate Professor Udantha Abeyratne at The University of Queensland, has pioneered algorithms that accurately characterise the state of patients’ respiratory tracts. The team has created a powerful platform for respiratory disease diagnosis and management which only requires the sound of the patient’s cough or breathing and does not require physical contact. With the high quality microphones in today’s smartphones the platform can be delivered without the need for additional hardware.

Recent Press

Coughs say a lot about your health, if your smartphone is listening

September 8, 2021
The Wall Street Journal

Few things are as annoying—or in the pandemic era as frightening—as the sound of a cough. But that same sound could help save lives. Researchers around the world are trying to turn the humble cough into an inexpensive tool to diagnose and stop respiratory-disease killers like tuberculosis and Covid-19. Read the article

ResApp Logo White

ResApp Health Limited
ABN 51 094 468 318
Level 12, 100 Creek St,
Brisbane, QLD 4000, Australia

  

© 2021 ResApp Health Limited. All rights reserved.